0 CHECKOUT

Germany Pharmaceuticals and Healthcare Report Q4 2015

  • ID: 3388040
  • August 2015
  • Region: Germany
  • 119 pages
  • Business Monitor International
1 of 4

FEATURED COMPANIES

  • Bayer Health Care
  • Boehringer Ingelheim
  • GlaxoSmithKline (GSK)
  • Grünenthal
  • Merck & Co
  • Merck KGaA
  • MORE

As the German economy observes signs of a tentative long-term rebalancing in which private consumption will play a more significant role in economic growth, recent improvements in high frequency indicators have lead us to an upward revision of the pharmaceutical market growth forecast for 2015.

However, the pharmaceutical market growth potential will continue to suffer significant downward pressure due to a challenging reimbursement and pricing environment, setting a pattern of marginal market expansion over the next few years.

In Q415 Germany retains a RRI score of 69.2 out of 100 after a downward revision in H115. Germany remains ranked as the fourth most attractive market to pharmaceutical investors out of 15 markets in the Western Europe region in our RRI matrix. While high market expenditure indices and risks scores are illustrative of the country's relative attractiveness and favourable operating environment, potential industry rewards are capped by increasingly burdensome reimbursement and pricing regulation.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Bayer Health Care
  • Boehringer Ingelheim
  • GlaxoSmithKline (GSK)
  • Grünenthal
  • Merck & Co
  • Merck KGaA
  • MORE

SWOT

Political

Economic

Operational Risk

Industry Forecast

Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Germany 2011-2019)

Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Germany 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Germany 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Germany 2011-2019)

Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Germany 2011-2019)
Table: Retail Pharmaceutical Expenditure, 2003-2010 (EURbn)
Table: Retail Pharmaceutical Expenditure, 2003-2010 (Packages, ms)
Table: Retail Pharmaceutical Expenditure, 2003-2010 (Average Price per Pack, EUR)

Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Germany 2011-2019)

Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Germany 2011-2019)

OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Germany 2011-2019)

Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Germany 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Germany 2013-2019)

Key Risks To Forecast Scenario

Macroeconomic Forecasts

Economic Analysis

GDP By Expenditure

Risks To Outlook
Table: GDP By Expenditure (Germany 2012-2019)

Industry Risk Reward Index

Western Europe Risk/Reward Index - Q4 2015

Germany Risk/Reward Index

Rewards

Risks

Market Overview

Industry Trends And Developments

Epidemiology

Healthcare Sector

Health Insurance

Healthcare Sector Reforms
Table: Healthcare Resources (Germany 2009-2014)
Table: Healthcare Personnel (Germany 2009-2014)
Table: Healthcare Activity (Germany 2009-2014)

Research & Development

Biotechnology Sector

Clinical Trials

Regulatory Development

Intellectual Property Regime

Pricing Regime
Table: Price Build-Up In The German Pharmaceutical Market

Reimbursement Regime

Parallel Imports

Competitive Landscape

Wholesale Sector

Retail Sector

Company Profile

Bayer Health Care

Boehringer Ingelheim

GlaxoSmithKline (GSK)

Grünenthal

Merck KGaA

Merck & Co

Pfizer

Sanofi

STADA Arzneimittel

Demographic Forecast

Demographic Outlook
Table: Population Headline Indicators (Germany 1990-2025)
Table: Key Population Ratios (Germany 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Germany 1990-2025)
Table: Population By Age Group (Germany 1990-2025)
Table: Population By Age Group % (Germany 1990-2025)

Glossary

Methodology

Pharmaceutical Expenditure Forecast Model

Healthcare Expenditure Forecast Model

Notes On Methodology

Risk/Reward Index Methodology

Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators

Indicator Weightings

Note: Product cover images may vary from those shown
3 of 4

Bayer Health Care
Boehringer Ingelheim
GlaxoSmithKline (GSK)
Grünenthal
Merck KGaA
Merck & Co
Pfizer
Sanofi
STADA Arzneimittel

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Pfizer Inc.
  • Grünenthal GmbH
  • GlaxoSmithKline PLC
  • Abbott Laboratories Ltd.
  • Roche Diagnostics Ltd.
  • Novo Nordisk A/S